Compare Immunovant Inc. Common Stock (IMVT) vs Mondaycom Ltd (MNDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Mondaycom Ltd — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Mondaycom Ltd trades at $88.99 (market cap $3.53B). The key difference: Immunovant Inc. Common Stock is the larger of the two by market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, Mondaycom Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Mondaycom Ltd for 16 Days on average.
| IMVT | MNDY | |
|---|---|---|
Market Cap | $6.62B | $3.53B |
Volume | 1,131,364 | 583,371 |
Sector | Health | Technology |
52-Week High | $44.96 | $205.24 |
52-Week Low | $17.03 | $58.81 |
Typical Hold Time | 0 Days | 16 Days |
Enterprise Value | $5.72B | $2.69B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Monday.com (MNDY) trades at $83.51, down 0.93% on the day, with a bearish technical signal and neutral oscillators. The stock shows strong fundamentals with revenue growth from $1.2B in 2025 to $1.4B in 2026 and consistent earnings beats. Recent news highlights its inclusion in growth stock lists and an upcoming AI-focused conference, Elevate '26.
The outlook is positive given analyst consensus of $110.42 price target and 65% buy ratings, but risks include competitive pressure from Meta's enterprise push and volatile cash flow trends. Investment appeal hinges on execution of AI initiatives and high-value client growth against premium valuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Mondaycom Ltd
Monday.com Ltd. is a cloud-based software company providing a Work OS (Operating System) that enables organizations to manage projects, processes, and daily work. The platform is highly customizable, enabling teams to build tailored applications and workflows for a range of use cases, from marketing and sales to software development and HR. monday.com serves clients across numerous industries, aiming to improve transparency, collaboration, and efficiency across the entire enterprise.
Read more on MNDY →
